SHPH
Shuttle Pharmaceuticals Holding
$0.69
-2.37%
2026-05-08
About Shuttle Pharmaceuticals Holding
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Key Fundamentals
EPS (TTM)
$-7.16
ROE
-791.0%
Profit Margin
0.0%
Debt/Equity
10.30
Price/Book
0.63
Beta
1.41
Market Cap
$4.0M
Avg Volume (10D)
4.4M
Recent Breakout Signals
No recent breakout signals detected for SHPH.
Recent Price Range (60 Days)
60D High
$1.19
60D Low
$0.50
Avg Volume
747K
Latest Close
$0.69
Get breakout alerts for SHPH
Sign up for Breakout Scanner to receive daily notifications when SHPH triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Shuttle Pharmaceuticals Holding (SHPH) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SHPH daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SHPH operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.